Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CTNMContineum Therapeutics, Inc.

Nasdaq · CIK 0001855175
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts202

Identity from submissions API

NameContineum Therapeutics, Inc.
CIK0001855175
TickersCTNM
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN271467257
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 333-5280
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3565 GENERAL ATOMICS COURT, SUITE 200
SAN DIEGO
CA
92121
CA
Mailing address
3565 GENERAL ATOMICS COURT, SUITE 200
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

204 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000256 005-94496 261558426 34 13189
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005041 005-94496 261555050 34 15101
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000904454-26-000591 005-94496 261529971 34 9901
2026-11-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002728 005-94496 261526126 34 11739
2026-11-04 144 xsl144X01/primary_doc.xml 0001950047-26-010677 001-42001 261522691 33 6330
2026-11-03 10-Q 10-Q 0001628280-26-069515 001-42001 261517562 34 7106783 1 1
2026-11-03 8-K 8-K 2.02,9.01 0001628280-26-069493 001-42001 261517448 34 254387 1 1
2026-10-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002050709-26-000029 005-94496 261495962 34 81665
2026-10-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000038777-26-000276 005-94496 261494539 34 26364
2026-10-22 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-048104 005-94496 261479046 34 24161
2026-10-01 144 xsl144X01/primary_doc.xml 0001950047-26-009932 001-42001 261431621 33 8503
2026-09-14 8-K 8-K 8.01,9.01 0001628280-26-061834 001-42001 261377407 34 179559 1 1
2026-09-08 4 FORM 4 0001628280-26-060962 9123
2026-09-08 144 xsl144X01/primary_doc.xml 0001950047-26-009206 001-42001 261365424 33 7141
2026-09-01 144 xsl144X01/primary_doc.xml 0001950047-26-008923 001-42001 261351322 33 9820
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003422 005-94496 261275803 34 15152
2026-08-03 4 FORM 4 0001628280-26-052031 9123
2026-08-03 144 xsl144X01/primary_doc.xml 0001950047-26-007517 001-42001 261233198 33 6412
2026-08-03 144 xsl144X01/primary_doc.xml 0001950047-26-007509 001-42001 261233160 33 10046
2026-07-30 10-Q 10-Q 0001628280-26-051054 001-42001 261223415 34 6184021 1 1
2026-07-30 8-K 8-K 2.02,9.01 0001628280-26-051051 001-42001 261223340 34 259138 1 1
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002243 005-94496 261206048 34 10970
2026-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-084693 005-94496 261184489 34 16005
2026-07-13 8-K 8-K 7.01,9.01 0001628280-26-048023 001-42001 261171492 34 4438216 1 1
2026-07-10 4 FORM 4 0001628280-26-047909 14083
2026-07-08 4 FORM 4 0001628280-26-047710 8587
2026-07-08 144 xsl144X01/primary_doc.xml 0001950047-26-006968 001-42001 261162791 33 5683
2026-07-02 4 FORM 4 0001628280-26-047058 17459
2026-07-01 4 FORM 4 0001628280-26-046654 9516
2026-07-01 4 FORM 4 0001628280-26-046653 12923
2026-07-01 144 xsl144X01/primary_doc.xml 0001950047-26-006723 001-42001 261145799 33 8600
2026-06-30 144 xsl144X01/primary_doc.xml 0001950047-26-006667 001-42001 261141071 33 7060
2026-06-30 144 xsl144X01/primary_doc.xml 0001950047-26-006666 001-42001 261141066 33 4955
2026-06-30 144 xsl144X01/primary_doc.xml 0001950047-26-006664 001-42001 261141054 33 4863
2026-06-26 4 FORM 4 0001628280-26-045845 6080
2026-06-26 4 FORM 4 0001628280-26-045843 6127
2026-06-26 4 FORM 4 0001628280-26-045841 6099
2026-06-26 4 FORM 4 0001628280-26-045839 6123
2026-06-26 4 FORM 4 0001628280-26-045837 6127
2026-06-26 4 FORM 4 0001628280-26-045835 6072
2026-06-26 4 FORM 4 0001628280-26-045833 6128
2026-06-26 8-K 8-K 5.07 0001628280-26-045804 001-42001 261130116 34 157121 1 1
2026-06-01 4 FORM 4 0001628280-26-039641 6381
2026-06-01 144 xsl144X01/primary_doc.xml 0001950047-26-005377 001-42001 261051127 33 7053
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000151 005-94496 26988857 34 14776
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225199 005-94496 26982043 34 133834
2026-05-05 10-Q 10-Q 0001628280-26-030614 001-42001 26943636 34 5715889 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001628280-26-030522 001-42001 26943151 34 240379 1 1
2026-05-01 4 FORM 4 0001628280-26-029435 8141
2026-05-01 144 xsl144X01/primary_doc.xml 0001950047-26-003933 001-42001 26933468 33 9956
2026-04-30 ARS ARS 0001628280-26-028900 001-42001 26925494 34 37827857
2026-04-30 DEFA14A DEFA14A 0001628280-26-028895 001-42001 26925416 34 1814045
2026-04-30 DEF 14A DEF 14A 0001628280-26-028881 001-42001 26925283 34 1424096 1 1
2026-04-30 8-K 8-K 7.01,8.01,9.01 0001628280-26-028876 001-42001 26925188 34 2483085 1 1
2026-04-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-044936 005-94496 26872209 34 15429
2026-04-06 4 FORM 4 0001628280-26-023949 6202
2026-04-06 144 xsl144X01/primary_doc.xml 0001950047-26-003275 001-42001 26841697 33 9224
2026-03-05 S-8 S-8 0001628280-26-015215 333-294051 26726388 33 366390 1 1
2026-03-05 424B5 424B5 0001628280-26-015205 333-287275 26726331 33 508232
2026-03-05 10-K 10-K 0001628280-26-015165 001-42001 26726175 34 9497799 1 1
2026-03-05 8-K 8-K 2.02,8.01,9.01 0001628280-26-015159 001-42001 26726128 34 402721 1 1
2026-03-02 4 FORM 4 0001437749-26-006422 5807
2026-03-02 4 FORM 4 0001437749-26-006421 8814
2026-02-26 4 FORM 4 0001437749-26-005892 14148
2026-02-26 4 FORM 4 0001437749-26-005889 14807
2026-02-20 4 FORM 4 0001437749-26-004912 8863
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-26-000037 005-94496 26641869 34 14819
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000079 005-94496 26639029 34 12391
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-052863 005-94496 26636081 34 126313
2026-02-13 4 FORM 4 0001437749-26-004126 8473
2026-02-13 4 FORM 4 0001437749-26-004122 8863
2026-02-11 144 xsl144X01/primary_doc.xml 0001950047-26-001158 001-42001 26621204 33 7289
2026-02-11 144 xsl144X01/primary_doc.xml 0001950047-26-001156 001-42001 26621194 33 5182
2026-02-05 4 FORM 4 0001437749-26-003212 7750
2026-02-03 144 xsl144X01/primary_doc.xml 0001950047-26-000891 001-42001 26593611 33 6327
2026-01-30 4 FORM 4 0001437749-26-002579 5256
2026-01-30 4 FORM 4 0001437749-26-002578 5225
2026-01-30 4 FORM 4 0001437749-26-002577 5286
2026-01-30 4 FORM 4 0001437749-26-002576 7688
2026-01-30 4 FORM 4 0001437749-26-002575 12997
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-26-000010 005-94496 26575543 34 25648
2026-01-26 8-K FORM 8-K 5.02,9.01 0001437749-26-002072 001-42001 26560563 34 164359 1 1
2026-01-06 4 FORM 4 0001437749-26-000616 7751
2026-01-05 144 xsl144X01/primary_doc.xml 0001950047-26-000145 001-42001 26507164 33 5601
2025-12-30 4 FORM 4 0001437749-25-038938 8815
2025-12-30 4 FORM 4 0001437749-25-038936 6074
2025-12-29 144 xsl144X01/primary_doc.xml 0001950047-25-010732 001-42001 251609488 33 5093
2025-12-23 144 xsl144X01/primary_doc.xml 0001950047-25-010672 001-42001 251600851 33 4872
2025-12-15 8-K FORM 8-K 1.01,8.01,9.01 0001437749-25-037842 001-42001 251571591 34 554784 1 1
2025-12-12 424B5 FORM 424B5 0001437749-25-037749 333-287275 251568976 33 603470
2025-12-11 424B5 FORM 424B5 0001437749-25-037553 333-287275 251565108 33 605173
2025-12-11 8-K FORM 8-K 8.01,9.01 0001437749-25-037547 001-42001 251564887 34 168531 1 1
2025-11-20 8-K FORM 8-K 8.01,9.01 0001437749-25-035860 001-42001 251503120 34 186348 1 1
2025-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000213 005-94496 251447050 34 17619
2025-10-30 10-Q FORM 10-Q 0001437749-25-032427 001-42001 251435698 34 6846131 1 1
2025-10-30 8-K FORM 8-K 2.02,9.01 0001437749-25-032422 001-42001 251435589 34 268437 1 1
2025-09-18 8-K FORM 8-K 7.01,8.01,9.01 0001437749-25-029349 001-42001 251321818 34 1004844 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-108947 005-94496 251219776 34 10803
2025-08-05 10-Q FORM 10-Q 0001437749-25-024852 001-42001 251185129 34 6197869 1 1
2025-08-05 8-K FORM 8-K 2.02,9.01 0001437749-25-024849 001-42001 251185018 34 268329 1 1
2025-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000140 005-94496 251183491 34 21855
2025-07-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-020291 005-94496 251152285 34 19053
2025-06-26 4 FORM 4 0001437749-25-021373 5710
2025-06-26 4 FORM 4 0001437749-25-021372 5723
2025-06-26 4 FORM 4 0001437749-25-021371 5672
2025-06-26 4 FORM 4 0001437749-25-021369 5727
2025-06-26 4 FORM 4 0001437749-25-021367 5727
2025-06-26 4 FORM 4 0001437749-25-021366 5699
2025-06-26 4 FORM 4 0001437749-25-021365 5680
2025-06-26 8-K FORM 8-K 5.07 0001437749-25-021343 001-42001 251080420 34 164858 1 1
2025-05-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001732 333-287275 25984037 33 1861
2025-05-21 CORRESP filename1.htm 0001437749-25-018028 10882
2025-05-20 UPLOAD filename1.pdf 0000000000-25-005357 333-287275 40263
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072735 005-94496 25954081 34 10751
2025-05-14 S-8 FORM S-8 0001437749-25-016878 333-287276 25946644 33 280179
2025-05-14 8-K FORM 8-K 2.02,8.01,9.01 0001437749-25-016877 001-42001 25946591 34 269107 1 1
2025-05-14 S-3 FORM S-3 0001437749-25-016871 333-287275 25946541 33 1513822
2025-05-14 10-Q FORM 10-Q 0001437749-25-016835 001-42001 25945465 34 5632500 1 1
2025-04-29 ARS ARS 0001437749-25-013556 001-42001 25888794 34 6176042
2025-04-29 DEFA14A FORM DEFA14A 0001437749-25-013532 001-42001 25887749 34 574710
2025-04-29 DEF 14A FORM DEF 14A 0001437749-25-013528 001-42001 25887238 34 2842832 1 1
2025-04-28 4 FORM 4 0001437749-25-013340 7854
2025-04-28 3 FORM 3 0001437749-25-013335 11483
2025-04-28 8-K FORM 8-K 8.01,9.01 0001437749-25-013334 001-42001 25880427 34 201466 1 1
2025-03-17 4 FORM 4 0001437749-25-008003 5295
2025-03-17 3 FORM 3 0001437749-25-008001 12641
2025-03-17 8-K FORM 8-K 5.02,9.01 0001437749-25-007998 001-42001 25744456 34 177739 1 1
2025-03-06 S-8 FORM S-8 0001437749-25-006459 333-285595 25715388 33 181357
2025-03-06 10-K FORM 10-K 0001437749-25-006458 001-42001 25715295 34 11771028 1 1
2025-03-06 8-K FORM 8-K 2.02,9.01 0001437749-25-006457 001-42001 25715254 34 293673 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021230 005-94496 25628920 34 10811
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013643 005-94496 25624768 34 13203
2025-01-31 4 FORM 4 0001437749-25-002436 5337
2025-01-31 4 FORM 4 0001437749-25-002435 5270
2025-01-31 4 FORM 4 0001437749-25-002431 7821
2025-01-31 4 FORM 4 0001437749-25-002429 5316
2025-01-31 4 FORM 4 0001437749-25-002424 5350
2024-11-27 4 FORM 4 0001437749-24-036349 5797
2024-11-20 4 FORM 4 0001437749-24-035887 7361
2024-11-18 144 xsl144X01/primary_doc.xml 0001950047-24-008738 001-42001 241472309 33 4905
2024-11-14 SC 13G SC 13G 0001104659-24-119059 005-94496 241463481 34 61684
2024-11-06 10-Q FORM 10-Q 0001437749-24-033616 001-42001 241431029 34 6723948 1 1
2024-11-06 8-K FORM 8-K 2.02,9.01 0001437749-24-033614 001-42001 241430966 34 305188 1 1
2024-10-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-24-000154 005-94496 241414122 34 25822
2024-08-14 4 FORM 4 0001437749-24-026903 6783
2024-08-14 10-Q FORM 10-Q 0001437749-24-026680 001-42001 241205906 34 6365617 1 1
2024-08-14 8-K/A FORM 8-K/A 2.02,7.01,9.01 0001437749-24-026664 001-42001 241205753 34 318694 1 1
2024-08-13 8-K FORM 8-K 2.02,9.01 0001437749-24-026385 001-42001 241201526 34 301187 1 1
2024-06-24 4 SARAH BOYCE FORM 4 0001437749-24-021091 5404
2024-06-24 3 SARAH BOYCE FORM 3 0001437749-24-021089 2952
2024-06-24 8-K FORM 8-K 5.02,9.01 0001437749-24-021083 001-42001 241064402 34 170516 1 1
2024-06-03 4 FORM 4 0001437749-24-019086 5339
2024-06-03 3 FORM 3 0001437749-24-019084 11519
2024-05-31 8-K FORM 8-K 5.02,9.01 0001437749-24-018934 001-42001 241010779 34 311375 1 1
2024-05-29 4 OPTION GRANT 0001437749-24-018626 5356
2024-05-29 4 OPTION GRANT 0001437749-24-018625 5277
2024-05-29 4 OPTION GRANT 0001437749-24-018624 7745
2024-05-29 4 OPTION GRANT 0001437749-24-018623 5322
2024-05-29 4 OPTION GRANT 0001437749-24-018622 5345
2024-05-29 4 OPTION GRANT 0001437749-24-018621 5317
2024-05-29 4 OPTION GRANT 0001437749-24-018620 5348
2024-05-29 4 OPTION GRANT 0001437749-24-018619 5293
2024-05-29 4 OPTION GRANT 0001437749-24-018618 5344
2024-05-20 3 FORM 3 0001437749-24-017720 11285
2024-05-20 4 FORM 4 0001437749-24-017719 5349
2024-05-20 8-K FORM 8-K 5.02,9.01 0001437749-24-017651 001-42001 24964501 34 168407 1 1
2024-05-16 10-Q FORM 10-Q 0001437749-24-017320 001-42001 24956531 34 5791704 1 1
2024-05-16 8-K FORM 8-K 2.02,9.01 0001437749-24-017293 001-42001 24955582 34 251646 1 1
2024-04-15 SC 13G d11024986_13-g.htm 0000919574-24-002557 005-94496 24845130 34 109212
2024-04-15 SC 13G SC 13G 0001193125-24-096240 005-94496 24844890 34 63673
2024-04-11 4 FORM 4 SUBMISSION 0000899243-24-000269 69478
2024-04-10 SC 13G s13g_040924-contineum.htm 0000904454-24-000255 005-94496 24836563 34 53008
2024-04-10 3 xslF345X02/ownership.xml 0000904454-24-000253 6271
2024-04-09 8-K 8-K 5.03,9.01 0001193125-24-090917 001-42001 24833291 34 230871
2024-04-09 S-8 S-8 0001193125-24-090909 333-278580 24833268 33 111501
2024-04-08 424B4 424B4 0001193125-24-088740 333-278003 24827817 33 7180756
2024-04-05 SEC STAFF LETTER filename1.pdf 9999999997-24-001812 64049
2024-04-04 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-04 16:00:00 9999999995-24-000863 333-278003 24824634 33 1868
2024-04-04 3 3 0000950170-24-042037 31815
2024-04-04 3 FORM 3 0001437749-24-011114 12843
2024-04-04 3 FORM 3 0001437749-24-011112 14229
2024-04-04 3 FORM 3 0001437749-24-011111 14169
2024-04-04 3 FORM 3 0001437749-24-011110 12788
2024-04-04 3 FORM 3 0001437749-24-011109 15432
2024-04-04 3 FORM 3 0001437749-24-011108 15397
2024-04-04 3 FORM 3 0001437749-24-011107 21217
2024-04-04 3 FORM 3 0001437749-24-011106 17021
2024-04-04 CERT 8A_Cert_IPO_CTNM.pdf 0001354457-24-000230 001-42001 24822686 34 250564
2024-04-02 8-A12B 8-A12B 0001193125-24-084743 001-42001 24814115 34 14406
2024-04-02 CORRESP filename1.htm 0001193125-24-084740 12079
2024-04-02 CORRESP filename1.htm 0001193125-24-084731 10151
2024-04-01 S-1/A S-1/A 0001193125-24-082755 333-278003 24805743 33 8857279
2024-03-21 CORRESP filename1.htm 0001193125-24-073237 76349
2024-03-15 CORRESP filename1.htm 0001193125-24-069271 36613
2024-03-15 S-1 S-1 0001193125-24-069256 333-278003 24755793 33 9893436
2024-02-23 UPLOAD filename1.pdf 0000000000-24-002089 377-06994 43324
2024-02-15 DRSLTR filename1.htm 0000950123-24-002678 40125
2024-02-15 DRS/A filename1.htm 0000950123-24-002677 377-06994 24644390 33 7238709
2024-02-07 UPLOAD filename1.pdf 0000000000-24-001505 377-06994 46501
2024-01-29 DRSLTR filename1.htm 0000950123-24-000444 99797
2024-01-29 DRS/A filename1.htm 0000950123-24-000443 377-06994 24574568 33 6977695
2024-01-25 SEC STAFF LETTER filename1.pdf 9999999997-24-000219 65177
2024-01-11 UPLOAD filename1.pdf 0000000000-24-000410 377-06994 59981
2023-12-13 DRS filename1.htm 0000950123-23-011163 377-06994 231482279 33 9354073

Latest XBRL company facts

One latest value per concept from companyfacts (202 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 23.10M 2025-10-27 2025 Q3 10-Q 2025-10-30 0001437749-25-032427
dei EntityPublicFloat Entity Public Float USD 102.10M 2025-06-30 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 641,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4.66M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 142,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.96M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.51M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 472.57M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 467,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.86M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 6.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap Assets Assets USD 256.99M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AssetsCurrent Assets, Current USD 249.74M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 243.96M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 263,000 2025-12-31 2026 Q2 10-Q 2026-07-30 0001628280-26-051054
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3,000 2025-12-31 2026 Q2 10-Q 2026-07-30 0001628280-26-051054
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 187.03M 2025-12-31 2026 Q2 10-Q 2026-07-30 0001628280-26-051054
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 187.29M 2025-12-31 2026 Q2 10-Q 2026-07-30 0001628280-26-051054
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 75.20M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 74.67M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 244.50M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 75.20M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -405,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 14.47M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 220.00M 2024-04-09 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.38M 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.38M 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -50.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 400,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2024-09-30 2024 Q3 10-Q 2024-11-06 0001437749-24-033616
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 26.88M 2025-12-31 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 3,000 2025-12-31 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 152 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.74M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 49.70M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.74M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 33.12M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 808,000 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 9.09M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.18M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 47.96M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.60M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 134,000 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 298,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001437749-24-033616
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.199 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.024 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.051 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.49M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 34.80M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.089 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-10-30 0001437749-25-032427
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -67,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0001437749-25-024852
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 14.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -60.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -60.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 11.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 1.02M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 422,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 708,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -364,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 233,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends shares 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001437749-24-033616
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap IncrementalCommonSharesAttributableToWrittenPutOptions Incremental Common Shares Attributable to Dilutive Effect of Written Put Options shares 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001437749-24-026680
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 579,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap Liabilities Liabilities USD 11.57M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 256.99M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.03M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 169.29M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 21.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 16.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -38.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -48.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -44.82M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-10-30 0001437749-25-032427
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -42.26M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingExpenses Operating Expenses USD 55.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -55.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.72M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.54M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.10M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 160,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -216,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 140,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 158.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 318,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 193.46M 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.26M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 19.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 175.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 779,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.79M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 848,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 40.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -225.69M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 3.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 18.56M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.97M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 9.46 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 4,200 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 271,428 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 11.92 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 22.01M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.2 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 22.01M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 7.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 11.2 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 15.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 14.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 245.42M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 399,222 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 192.62M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 780,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 19.01M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-10-30 0001437749-25-032427
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 22,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.10M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 192.62M 2023-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 193,462 2024-03-31 2024 Q1 10-Q 2024-05-16 0001437749-24-017320
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 15.91M 2024-04-09 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 3.56M 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 470,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001628280-26-015165
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 37.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515
us-gaap WeightedAverageNumberOfSharesContingentlyIssuable Weighted Average Number of Shares, Contingently Issuable shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 19.35M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0001437749-25-006458
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 37.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069515

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →